Search

One of the materials that has recently been used to remove environmental pollution from industrial effluents with photocatalytic technology is cobalt chromate (CoCr2O4) nanoparticles. An effective way to improve the photocatalytic properties of materials is to composite them with other photocatalysts to prevent recombination of electron-holes and accelerate the transfer of oxidation/reduction agents. Graphitic carbon nitride (g-C3N4) is an excellent choice due to its unique properties. In this research, CoCr2O4 and its composite with g-C3N4 (5, 10, and 15%) were synthesized by polyacrylamide gel method and characterized by X-ray diffraction, scanning electron microscopy, FTIR, UV–Vis spectroscopy techniques. The photocatalytic behavior of synthesized nanoparticles was investigated in the degradation process of methylene blue dye. The results showed that the composite samples have higher efficiency in photocatalytic activity than the pure CoCr2O4 sample. Using CoCr2O4-15 wt%g-C3N4 nanocomposite, after 80 min, methylene blue was completely degraded. The mechanism of degradation by CoCr2O4-g-C3N4 nanocomposite was the superoxide radical produced by the reaction of electrons with oxygen absorbed on the catalyst surface, as well as optically produced holes directly. [ABSTRACT FROM AUTHOR]

The dense extracellular matrix (ECM) in the tumor microenvironment forms an abnormal physical barrier, which impedes the delivery and penetration of nanomedicines and hinders their therapeutic efficacy. Herein, we synthesize matrix-degrading soft-nanocapsules composed of human serum albumin (HSA) and hyaluronidase (HAase) for overcoming the obstruction of ECM in the tumor microenvironment. The matrix-degrading human serum albumin/hyaluronidase soft-nanocapsules, referred to as HSA/HAase SNCs, possess a uniform diameter, inward hollow structure, and wrinkled morphology. In vitro biocompatibility results indicate that the HSA/HAase SNCs display no adverse effects on the viability of human umbilical vein endothelial cells (HUVECs), smooth muscle cells (SMCs), and mouse breast cancer (4T1) cells and do not induce hemolysis towards red blood cells (RBCs). The HSA/HAase SNCs exhibit a 1.4-fold increase in tumor cellular uptake compared to the stiff-counterparts and enhanced penetration in 4T1-, mouse colon carcinoma 26- (CT26-), and mouse pancreatic cancer- (PanO 2 -) multicellular spheroids. Thanks to the advanced biological properties, a photodynamic platform prepared by loading Ce6 in the HSA/HAase SNCs (HSA/HAase@Ce6) shows improved reactive oxygen species production, a stronger killing effect for cancer cells, and deeper penetration in tumor tissues. In vivo experiments show that HSA/HAase@Ce6 effectively inhibits tumor growth in breast cancer mouse models. RNA-seq analysis of the mice that received the treatment of HSA/HAase@Ce6 shows enrichment of signaling pathways associated with ECM-degradation, which demonstrates that the matrix-degrading nanocapsules overcome the ECM-induced physical barriers in tumors. Overall, the matrix-degrading soft-nanoplatform represents a highly promising strategy to overcome ECM-induced physical barriers and enhance the therapeutic efficacy of nanomedicines.